Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?

In this Western Hemisphere cohort of early-stage ENKTCL patients treated with CMT, ENI may have a potential clinical benefit, particularly in patients who are treated with non-asparaginase-containing CMT, such as in patients treated with radiation alone, patients treated with less intensive chemotherapy concurrently, or patients who are unable to tolerate intensive chemotherapy.

Authors

Institutions

Publication Details

Journal
Advances in Radiation Oncology
Published
2024-10-09
DOI
https://doi.org/10.1016/j.adro.2024.101650
Citations
1
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?

L. Jeffrey Medeiros, Bouthaina Shbib Dabaja, Chelsea C. Pinnix, Jason R. Westin et al.
1 citations
Advances in Radiation Oncology
Lymphoma Diagnosis and Treatment
0.42
article

Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?

L. Jeffrey Medeiros, Bouthaina Shbib Dabaja, Chelsea C. Pinnix, Jason R. Westin, Ethan B. Ludmir, Swaminathan P. Iyer, Auris Huen, Luis Fayad, Jillian R. Gunther, Sonal S. Noticewala, Loretta J. Nastoupil, Paolo Strati, Sairah Ahmed, Sattva Swarup Neelapu, Penny Q. Fang, Chijioke Nze, Christopher R. Flowers, Susan Wu, Ranjit K. Nair, Luis Malpica Castillo
article en
1 citations

Abstract

In this Western Hemisphere cohort of early-stage ENKTCL patients treated with CMT, ENI may have a potential clinical benefit, particularly in patients who are treated with non-asparaginase-containing CMT, such as in patients treated with radiation alone, patients treated with less intensive chemotherapy concurrently, or patients who are unable to tolerate intensive chemotherapy.

Advances in Radiation OncologyVol. 9(12)
The University of Texas MD Anderson Cancer Center (US)
Leukemia and Lymphoma Society, Gilead Sciences, Andrew Sabin Family Foundation, National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute
Zero hunger
Openalex Percentile: Top 34%
Lymphoma Diagnosis and Treatment
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.